Last update 01 Nov 2024

Tianjin Madison Regenerative Medicine Co., Ltd.

Private Company|
2006|
Tianjin Shi, China

Overview

Tags

Immune System Diseases
Mesenchymal stem cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Immune System Diseases1
Top 5 Drug TypeCount
Mesenchymal stem cell therapy1

Related

1
Drugs associated with Tianjin Madison Regenerative Medicine Co., Ltd.
Pontmestrocel
Target-
Mechanism
Stem cell replacements
Active Org.
Tianjin Madison Regenerative Medicine Co., Ltd.
Originator Org.
Chinese Academy of Medical SciencesChinese Academy of Medical Sciences
Active Indication
Graft vs Host Disease
Inactive Indication
Acute Graft Versus Host Disease [+1]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Tianjin Madison Regenerative Medicine Co., Ltd.
CTR20230686 / RecruitingPhase 3
人原始间充质干细胞对治疗移植物抗宿主病（GVHD）的研究
[Translation] Study on the effect of human primitive mesenchymal stem cells on the treatment of graft-versus-host disease (GVHD)
100 Clinical Results associated with Tianjin Madison Regenerative Medicine Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Tianjin Madison Regenerative Medicine Co., Ltd.
Login to view more data
100 Deals associated with Tianjin Madison Regenerative Medicine Co., Ltd.
Login to view more data
100 Translational Medicine associated with Tianjin Madison Regenerative Medicine Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pontmestrocel
Graft vs Host Disease
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free